Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Dementias

Section edited by Marwan Sabbagh

This section focuses on neurodegeneration. Topics of interest include, but are not limited to, Alzheimer’s disease, Parkinson’s Disease, frontotemporal dementias, Lewy body dementia, vascular dementia, mild cognitive impairment and basic aspects of neurodegenerative diseases and prion diseases.

Page 4 of 4

  1. Mild cognitive impairment (MCI) is a heterogeneous clinical entity that comprises the prodromal phase of Alzheimer's disease (Pr-AD). New biomarkers are useful in detecting Pr-AD, but they are not universally ...

    Authors: Ana Pozueta, Eloy Rodríguez-Rodríguez, José Luis Vazquez-Higuera, Ignacio Mateo, Pascual Sánchez-Juan, Soraya González-Perez, José Berciano and Onofre Combarros

    Citation: BMC Neurology 2011 11:78

    Content type: Research article

    Published on:

  2. Donepezil 23 mg/d, recently approved in the United States for treatment of moderate to severe Alzheimer's disease (AD), was developed to address the need for an additional treatment option for patients with ad...

    Authors: Martin Farlow, Felix Veloso, Margaret Moline, Jane Yardley, Elimor Brand-Schieber, Francesco Bibbiani, Heng Zou, Timothy Hsu and Andrew Satlin

    Citation: BMC Neurology 2011 11:57

    Content type: Research article

    Published on:

  3. Despite being the fastest growing and the most cognitively impaired age group, the oldest olds are under-represented in clinical research. The purpose of this study was to describe the design, methods, and bas...

    Authors: Ugo Lucca, Mariateresa Garrì, Angela Recchia, Giancarlo Logroscino, Pietro Tiraboschi, Massimo Franceschi, Chiara Bertinotti, Anna Biotti, Elena Gargantini, Marilena Maragna, Alessandro Nobili, Luca Pasina, Carlotta Franchi, Emma Riva and Mauro Tettamanti

    Citation: BMC Neurology 2011 11:54

    Content type: Research article

    Published on:

  4. Multiple pathogenic factors may contribute to the pathophysiology of Alzheimer's disease (AD). Peripheral blood markers have been used to assess biochemical changes associated with AD and mild cognitive impair...

    Authors: Sam-Moon Kim, Juhee Song, Seungwoo Kim, Changsu Han, Moon Ho Park, Youngho Koh, Sangmee Ahn Jo and Young-Youl Kim

    Citation: BMC Neurology 2011 11:51

    Content type: Research article

    Published on:

  5. Simple, non-invasive tests for early detection of degenerative dementia by use of biomarkers are urgently required. However, up to the present, no validated extracerebral diagnostic markers for the early diagn...

    Authors: Felix Bermejo-Pareja, Desiree Antequera, Teo Vargas, Jose A Molina and Eva Carro

    Citation: BMC Neurology 2010 10:108

    Content type: Research article

    Published on: